We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Warrior Met Coal
HCC
$4.88B
| $4.39M | 0.01% |
154,437
-26,802
| -15% | -$824K |
|
702
Ashland
ASH
$3.21B
| $4.33M | 0.01% |
45,552
+14,356
| +46% | +$1.46M |
|
703
TTM Technologies
TTMI
$11.9B
| $4.31M | 0.01% |
327,374
-45,789
| -12% | -$660K |
|
704
Dow Inc
DOW
$21.6B
| $4.3M | 0.01% |
97,838
-417,726
| -81% | -$21.2M |
|
705
Landstar System
LSTR
$5.72B
| $4.21M | 0.01% |
29,146
-13,844
| -32% | -$2.06M |
|
|
ORTX
706
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $4.2M | 0.01% |
840,169
+9,183
| +1% | +$51.1K |
|
707
Macy's
M
$5.71B
| $4.2M | 0.01% |
267,852
-66,461
| -20% | -$1.18M |
|
708
GrafTech
EAF
$210M
| $4.2M | 0.01% |
97,363
+97,214
| +65,244% | +$6.18M |
|
|
GRCL
709
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $4.18M | 0.01% |
1,298,578
| – | – |
|
710
Pediatrix Medical
MD
$2.12B
| $4.16M | 0.01% |
251,971
-51,140
| -17% | -$1.03M |
|
711
Archer Daniels Midland
ADM
$41B
| $4.15M | 0.01% |
51,588
-8,076
| -14% | -$665K |
|
712
Boeing
BA
$157B
| $4.13M | 0.01% |
34,125
-1,050
| -3% | -$161K |
|
713
CareDx
CDNA
$2.76B
| $4.12M | 0.01% |
242,175
+201,183
| +491% | +$4.32M |
|
714
Comstock Resources
CRK
$3.83B
| $4.11M | 0.01% |
237,494
+138,875
| +141% | +$2.3M |
|
|
VRNT
715
DELISTED
Verint Systems
VRNT
| $4.09M | 0.01% |
121,870
-92,014
| -43% | -$4.01M |
|
716
Range Resources
RRC
$9.09B
| $4.09M | 0.01% |
161,897
+79,007
| +95% | +$2.39M |
|
717
Allison Transmission
ALSN
$9.79B
| $4.05M | 0.01% |
120,140
-1,304
| -1% | -$48.8K |
|
718
TransUnion
TRU
$14.2B
| $4.03M | 0.01% |
67,766
-345
| -0.5% | -$26.5K |
|
|
AESC
719
DELISTED
The AES Corporation
AESC
| $4.01M | 0.01% |
45,336
| – | – |
|
|
HSII
720
DELISTED
Heidrick & Struggles
HSII
| $3.99M | 0.01% |
153,480
-181
| -0.1% | -$5.34K |
|
721
Ryder
R
$9.09B
| $3.99M | 0.01% |
52,842
-8,555
| -14% | -$651K |
|
|
RYZ
722
Ryerson Holding Corp
RYZ
$1.25B
| $3.98M | 0.01% |
154,630
+482
| +0.3% | +$12.8K |
|
723
Sylvamo
SLVM
$1.42B
| $3.94M | 0.01% |
116,285
+115,565
| +16,051% | +$4.39M |
|
|
ATVI
724
DELISTED
Activision Blizzard
ATVI
| $3.93M | 0.01% |
52,855
-37
| -0.1% | -$2.9K |
|
|
AGNT
725
AGNT Inc
AGNT
$643M
| $3.92M | 0.01% |
349,620
+346,030
| +9,639% | +$4.82M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.